453 related articles for article (PubMed ID: 18318765)
21. Rituximab for warm-type idiopathic autoimmune hemolytic anemia: a retrospective study of 11 adult patients.
D'Arena G; Califano C; Annunziata M; Tartarone A; Capalbo S; Villani O; Amendola G; Pietrantuono G; Ferrara F; Pinto A; Musto P; D'Arco AM; Cascavilla N
Eur J Haematol; 2007 Jul; 79(1):53-8. PubMed ID: 17532766
[TBL] [Abstract][Full Text] [Related]
22. Anti-CD20 antibody in thrombotic thrombocytopenic purpura refractory to plasma exchange.
Chow KV; Carroll R; Branley P; Nicholls K; Becker G; Hogan C
Intern Med J; 2007 May; 37(5):329-32. PubMed ID: 17504282
[TBL] [Abstract][Full Text] [Related]
23. Rituximab is effective in the management of refractory autoimmune cytopenias occurring after allogeneic stem cell transplantation.
Raj K; Narayanan S; Augustson B; Ho A; Mehta P; Duncan N; Tauro S; Mahendra P; Craddock C; Mufti G
Bone Marrow Transplant; 2005 Feb; 35(3):299-301. PubMed ID: 15568036
[TBL] [Abstract][Full Text] [Related]
24. Successful repeat therapy with rituximab for relapsed thrombotic thrombocytopenic purpura.
Patino W; Sarode R
J Clin Apher; 2007 Feb; 22(1):17-20. PubMed ID: 17285618
[TBL] [Abstract][Full Text] [Related]
25. Rituximab in autoimmune diseases.
Virgolini L; Marzocchi V
Biomed Pharmacother; 2004 Jun; 58(5):299-309. PubMed ID: 15194166
[TBL] [Abstract][Full Text] [Related]
26. Targeted ITP strategies: do they elucidate the biology of ITP and related disorders?
Bennett CM; de Jong JL; Neufeld EJ
Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):706-9. PubMed ID: 16933263
[TBL] [Abstract][Full Text] [Related]
27. Rituximab treatment for chronic refractory idiopathic thrombocytopenic purpura.
Zhou Z; Yang R
Crit Rev Oncol Hematol; 2008 Jan; 65(1):21-31. PubMed ID: 17681784
[TBL] [Abstract][Full Text] [Related]
28. B cells as a therapeutic target in autoimmune diseases other than rheumatoid arthritis.
Looney RJ
Rheumatology (Oxford); 2005 May; 44 Suppl 2():ii13-ii17. PubMed ID: 15851522
[TBL] [Abstract][Full Text] [Related]
29. Partial response to anti-CD20 monoclonal antibody treatment of severe immune thrombocytopenic purpura in a patient with common variable immunodeficiency.
Carbone J; Escudero A; Mayayo M; Ballesteros M; Perez-Corral A; Sanchez-Ramon S; Sarmiento E; Micheloud D; Fernandez-Cruz E
Ann N Y Acad Sci; 2005 Jun; 1051():666-71. PubMed ID: 16127007
[TBL] [Abstract][Full Text] [Related]
30. Sustained response to rituximab of autoimmune hemolytic anemia associated with antiphospholipid syndrome.
Erdozain JG; Ruiz-Irastorza G; Egurbide MV; Aguirre C
Haematologica; 2004 Sep; 89(9):ECR34. PubMed ID: 15377486
[TBL] [Abstract][Full Text] [Related]
31. Anti-CD20 monoclonal antibodies and their use in adult autoimmune hematological disorders.
Dierickx D; Delannoy A; Saja K; Verhoef G; Provan D
Am J Hematol; 2011 Mar; 86(3):278-91. PubMed ID: 21328427
[TBL] [Abstract][Full Text] [Related]
32. Chronic refractory idiopathic thrombocytopenic purpura (ITP) and anti-CD20 monoclonal antibody: a case report.
Latifzadeh SZ; Entezari V
Clin Appl Thromb Hemost; 2006 Oct; 12(4):489-92. PubMed ID: 17000895
[TBL] [Abstract][Full Text] [Related]
33. Successful treatment of severe thrombotic thrombocytopenic purpura with the monoclonal antibody rituximab.
Chemnitz J; Draube A; Scheid C; Staib P; Schulz A; Diehl V; Söhngen D
Am J Hematol; 2002 Oct; 71(2):105-8. PubMed ID: 12353309
[TBL] [Abstract][Full Text] [Related]
34. B cell-targeted therapy with rituximab and autoimmune neuromuscular disorders.
Stübgen JP
J Neuroimmunol; 2008 Nov; 204(1-2):1-12. PubMed ID: 18783837
[TBL] [Abstract][Full Text] [Related]
35. Anti B cell therapy (rituximab) in the treatment of autoimmune diseases.
Kazkaz H; Isenberg D
Curr Opin Pharmacol; 2004 Aug; 4(4):398-402. PubMed ID: 15251135
[TBL] [Abstract][Full Text] [Related]
36. Successful treatment of autoimmune hepatitis and idiopathic thrombocytopenic purpura with the monoclonal antibody, rituximab: case report and review of literature.
Santos ES; Arosemena LR; Raez LE; O'Brien C; Regev A
Liver Int; 2006 Jun; 26(5):625-9. PubMed ID: 16762009
[TBL] [Abstract][Full Text] [Related]
37. Acquired immune cytopenias post-cardiac transplantation respond to rituximab.
Tubman VN; Smoot L; Heeney MM
Pediatr Blood Cancer; 2007 Mar; 48(3):339-44. PubMed ID: 16435382
[TBL] [Abstract][Full Text] [Related]
38. [Delayed response to rituximab of cold agglutinin haemolytic disease].
Calvo-Villas JM; Cuesta Tovar J; Carreter de Granda E; Sicilia Guillén F
An Med Interna; 2006 May; 23(5):224-8. PubMed ID: 16817700
[TBL] [Abstract][Full Text] [Related]
39. Rituximab in the treatment of relapsing idiopathic thrombocytopenic purpura.
Riksen NP; Keuning JJ; Vreugdenhil G
Neth J Med; 2003 Jul; 61(7):262-5. PubMed ID: 14567524
[TBL] [Abstract][Full Text] [Related]
40. Rituximab in the treatment of relapsed thrombotic thrombocytopenic purpura.
Reddy PS; Deauna-Limayo D; Cook JD; Ganguly SS; Blecke C; Bodensteiner DC; Skikne BS; Sahud MA
Ann Hematol; 2005 Apr; 84(4):232-5. PubMed ID: 15517266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
